Medpace (NASDAQ: MEDP) director plans $3.0M stock sale

Rhea-AI Filing Summary

Medpace Holdings, Inc. (symbol MEDP) received a Rule 144 notice that director Brian T. Carley, through Fidelity Brokerage Services LLC, plans to sell up to 5,000 shares of Medpace common stock on or about 08/19/2026 on NASDAQ. The filing lists an aggregate market value of $3,043,155.23 for these shares and states that 27,911,655 shares of common stock were outstanding. The shares to be sold were acquired via restricted stock vesting of 104 shares on 03/31/2023 and a stock option exercise of 4,896 shares on 06/15/2023.

Key Figures

Shares to be sold: 5,000 shares Aggregate market value of shares to be sold: $3,043,155.23 Shares outstanding: 27,911,655 shares +3 more

6 metrics

Shares to be sold 5,000 shares Common stock covered by the Rule 144 notice for director Brian T. Carley

Aggregate market value of shares to be sold $3,043,155.23 Market value reported for the 5,000 common shares subject to the proposed sale

Shares outstanding 27,911,655 shares Medpace common shares outstanding as reported in the notice

Restricted stock acquired 104 shares Shares acquired via restricted stock vesting on 03/31/2023

Stock option exercise shares 4,896 shares Shares acquired via stock option exercise on 06/15/2023

Approximate sale date 08/19/2026 Date listed as the expected sale date for the 5,000 shares on NASDAQ

Key Terms

Rule 144, restricted stock vesting, stock option exercise, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 03/31/2023 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

stock option exercise financial

"Common | 06/15/2023 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing disclose for Medpace Holdings, Inc. (MEDP)?

The Form 144 discloses that director Brian T. Carley intends to sell up to 5,000 MEDP common shares under Rule 144. The proposed sale, through Fidelity Brokerage Services LLC on NASDAQ, has an aggregate market value of $3,043,155.23 according to the notice.

How many Medpace (MEDP) shares are proposed to be sold and at what value?

The notice covers a proposed sale of 5,000 MEDP common shares with an aggregate market value of $3,043,155.23. This value is reported in the filing as the market value associated with the shares to be sold under Rule 144.

Who is selling Medpace (MEDP) shares under this Form 144 and through which broker?

The securities are to be sold for the account of Brian T. Carley, a director of Medpace. The filing lists Fidelity Brokerage Services LLC as the broker handling the potential sale of MEDP common stock on NASDAQ under Rule 144.

When were the Medpace (MEDP) shares to be sold under Form 144 originally acquired?

The filing shows 104 shares acquired via restricted stock vesting on 03/31/2023 and 4,896 shares via stock option exercise on 06/15/2023. Together these acquisitions account for the 5,000 MEDP shares covered by the planned Rule 144 sale.

What is the reported number of Medpace (MEDP) shares outstanding in the Form 144?

The Form 144 reports that 27,911,655 MEDP common shares were outstanding. This figure is provided as context in the notice and is separate from the 5,000 shares proposed to be sold under Rule 144 by the reporting director.

On what date is the Medpace (MEDP) Rule 144 sale expected to occur?

The filing lists an approximate sale date of 08/19/2026 for the 5,000 MEDP common shares. This date is described as the expected timing for the Rule 144 transaction on NASDAQ through Fidelity Brokerage Services LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 04:42 PM Accepted by SEC EDGAR 08/19/2026 - 04:41 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001677791
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medpace Holdings, Inc.
SEC File Number	001-37856
Address of Issuer	5375 MEDPACE WAY CINCINNATI OHIO 45227
Phone	(513) 579-9911
Name of Person for Whose Account the Securities are To Be Sold	Carley Brian T
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5000	3043155.23	27911655	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2023	Restricted Stock Vesting	Issuer			104	03/31/2023	Compensation
Common	06/15/2023	Stock Option Exercise	Issuer			4896	06/15/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brian Carley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)